Page last updated: 2024-08-24

3-iodobenzylguanidine and Dyslipidemias

3-iodobenzylguanidine has been researched along with Dyslipidemias in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ascaso, JF; Carmena, R; Civera, M; Molina, M; Navarro, I; Real, JT1

Reviews

1 review(s) available for 3-iodobenzylguanidine and Dyslipidemias

ArticleYear
[Catecholamine-induced cardiomyopathy triggered by pheochromocytoma].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:4

    Topics: 3-Iodobenzylguanidine; Acute Coronary Syndrome; Adrenal Gland Neoplasms; Adrenalectomy; Catecholamines; Combined Modality Therapy; Diagnosis, Differential; Dyslipidemias; Female; Humans; Hypertension; Metanephrine; Middle Aged; Myocardial Infarction; Phenoxybenzamine; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Vanilmandelic Acid; Ventricular Dysfunction, Left

2011